Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ginny Mason

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
BMC Cancer|June 3, 2014
The SystHERs registry: an observational cohort study of treatment patterns and outcomes in patients with human epidermal growth factor receptor 2-positive metastatic breast cancerDebu Tripathy, Hope S Rugo, Peter A Kaufman, et al.
The Oncologist|February 12, 2020
De Novo Versus Recurrent HER2-Positive Metastatic Breast Cancer: Patient Characteristics, Treatment, and Survival from the SystHERs RegistryDebu Tripathy, Adam Brufsky, Melody Cobleigh, et al.
Breast Cancer Research and Treatment|December 24, 2025
Assessing the accuracy of inflammatory breast cancer self-reported diagnoses through the metastatic breast cancer project from the count me in initiative databasePietro De Placido, Elizabeth Troll, Samuel M Niman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 30, 2018
Central Nervous System Metastasis in Patients with HER2-Positive Metastatic Breast Cancer: Patient Characteristics, Treatment, and Survival from SystHERsSara A Hurvitz, Joyce O'Shaughnessy, Ginny Mason, et al.
Breast Cancer Research and Treatment|February 28, 2021
Baseline characteristics and first-line treatment patterns in patients with HER2-positive metastatic breast cancer in the SystHERs registryPeter A Kaufman, Sara A Hurvitz, Joyce O'Shaughnessy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 28, 2019
Baseline Characteristics, Treatment Patterns, and Outcomes in Patients with HER2-Positive Metastatic Breast Cancer by Hormone Receptor Status from SystHERsMelody Cobleigh, Denise A Yardley, Adam M Brufsky, et al.
BMC Medical Research Methodology|June 13, 2019
Effective stakeholder engagement: design and implementation of a clinical trial (SWOG S1415CD) to improve cancer careSarah Barger, Sean D Sullivan, Ari Bell-Brown, et al.
Journal of the National Cancer Institute|March 31, 2025
Development of a Multi-Institutional Dataset to Validate a Novel Inflammatory Breast Cancer Diagnostic ScoreFilipa Lynce, Samuel M Niman, Megumi Kai, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 11, 2023
Standardized Definitions for Efficacy End Points in Neoadjuvant Breast Cancer Clinical Trials: NeoSTEEPJennifer K Litton, Meredith M Regan, Lajos Pusztai, et al.
Breast (Edinburgh, Scotland)|June 19, 2024
6th and 7th International consensus guidelines for the management of advanced breast cancer (ABC guidelines 6 and 7)Fatima Cardoso, Shani Paluch-Shimon, Eva Schumacher-Wulf, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
BMC Cancer|June 3, 2014
The SystHERs registry: an observational cohort study of treatment patterns and outcomes in patients with human epidermal growth factor receptor 2-positive metastatic breast cancerDebu Tripathy, Hope S Rugo, Peter A Kaufman, et al.
The Oncologist|February 12, 2020
De Novo Versus Recurrent HER2-Positive Metastatic Breast Cancer: Patient Characteristics, Treatment, and Survival from the SystHERs RegistryDebu Tripathy, Adam Brufsky, Melody Cobleigh, et al.
Breast Cancer Research and Treatment|December 24, 2025
Assessing the accuracy of inflammatory breast cancer self-reported diagnoses through the metastatic breast cancer project from the count me in initiative databasePietro De Placido, Elizabeth Troll, Samuel M Niman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 30, 2018
Central Nervous System Metastasis in Patients with HER2-Positive Metastatic Breast Cancer: Patient Characteristics, Treatment, and Survival from SystHERsSara A Hurvitz, Joyce O'Shaughnessy, Ginny Mason, et al.
Breast Cancer Research and Treatment|February 28, 2021
Baseline characteristics and first-line treatment patterns in patients with HER2-positive metastatic breast cancer in the SystHERs registryPeter A Kaufman, Sara A Hurvitz, Joyce O'Shaughnessy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 28, 2019
Baseline Characteristics, Treatment Patterns, and Outcomes in Patients with HER2-Positive Metastatic Breast Cancer by Hormone Receptor Status from SystHERsMelody Cobleigh, Denise A Yardley, Adam M Brufsky, et al.
BMC Medical Research Methodology|June 13, 2019
Effective stakeholder engagement: design and implementation of a clinical trial (SWOG S1415CD) to improve cancer careSarah Barger, Sean D Sullivan, Ari Bell-Brown, et al.
Journal of the National Cancer Institute|March 31, 2025
Development of a Multi-Institutional Dataset to Validate a Novel Inflammatory Breast Cancer Diagnostic ScoreFilipa Lynce, Samuel M Niman, Megumi Kai, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 11, 2023
Standardized Definitions for Efficacy End Points in Neoadjuvant Breast Cancer Clinical Trials: NeoSTEEPJennifer K Litton, Meredith M Regan, Lajos Pusztai, et al.
Breast (Edinburgh, Scotland)|June 19, 2024
6th and 7th International consensus guidelines for the management of advanced breast cancer (ABC guidelines 6 and 7)Fatima Cardoso, Shani Paluch-Shimon, Eva Schumacher-Wulf, et al.
Pageof 2